{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T03:31:26Z","timestamp":1788838286336,"version":"build-2803163510"},"reference-count":112,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2022,3,24]],"date-time":"2022-03-24T00:00:00Z","timestamp":1648080000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,3,24]],"date-time":"2022-03-24T00:00:00Z","timestamp":1648080000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Biometals"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1007\/s10534-022-00386-5","type":"journal-article","created":{"date-parts":[[2022,3,24]],"date-time":"2022-03-24T20:53:12Z","timestamp":1648155192000},"page":"639-652","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Metal-based complexes against SARS-CoV-2"],"prefix":"10.1007","volume":"35","author":[{"given":"Kyriacos","family":"Ioannou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8356-0868","authenticated-orcid":false,"given":"Manos C.","family":"Vlasiou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,3,24]]},"reference":[{"key":"386_CR1","unstructured":"A Safety, Tolerability, and Efficacy of Molnupiravir (EIDD-2801) to Eliminate Infectious Virus Detection in Persons With COVID-19 - Full-Text View - ClinicalTrials.gov [Internet]. Clinicaltrials.gov. 2021. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04405570?term=Molnupiravir&draw=2&rank=6. Accessed 24 Nov 2021"},{"issue":"1","key":"386_CR2","doi-asserted-by":"publisher","first-page":"24","DOI":"10.5946\/ce.2013.46.1.24","volume":"46","author":"RR Allison","year":"2013","unstructured":"Allison RR, Moghissi K (2013) Photodynamic therapy (PDT): PDT mechanisms. Clin Endosc 46(1):24\u201329. https:\/\/doi.org\/10.5946\/ce.2013.46.1.24","journal-title":"Clin Endosc"},{"issue":"1","key":"386_CR3","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1111\/cmi.12343","volume":"17","author":"D Amatore","year":"2015","unstructured":"Amatore D, Sgarbanti R, Aquilano K, Baldelli S, Limongi D, Civitelli L, Nencioni L, Garcia E, Cirilo MR, Palamara AT (2015) Influenza virus replication in lung epithelial cells depends on redox-sensitive pathways activated by NOX4-derived ROS. Cell Microbiol 17(1):131\u2013145. https:\/\/doi.org\/10.1111\/cmi.12343","journal-title":"Cell Microbiol"},{"key":"386_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.drup.2020.100721","volume":"53","author":"A Artese","year":"2020","unstructured":"Artese A, Svicher V, Costa G, Salpini R, Di Maio VC, Alkhatib M, Ambrosio FA, Santoro MM, Assaraf YG, Alcaro S, Ceccherini-Silberstein F (2020) Current status of antivirals and druggable targets of SARS-CoV-2 and other human pathogenic coronaviruses. Drug Resist Update 53:100721. https:\/\/doi.org\/10.1016\/j.drup.2020.100721","journal-title":"Drug Resist Update"},{"issue":"5","key":"386_CR5","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1097\/00003226-199809000-00014","volume":"17","author":"PA Asbell","year":"1998","unstructured":"Asbell PA, Epstein SP, Wallace JA, Epstein D, Stewart CC, Burger RM (1998) Efficacy of cobalt chelates in the rabbit eye model for epithelial herpetic keratitis. Cornea 17(5):550\u2013557. https:\/\/doi.org\/10.1097\/00003226-199809000-00014","journal-title":"Cornea"},{"key":"386_CR6","unstructured":"Bharti S, Singh S (2009) Metal-based drugs: current use and future potential. Der Pharmacia Lett 1"},{"key":"386_CR7","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/4389089","volume":"2020","author":"M Bianchi","year":"2020","unstructured":"Bianchi M, Benvenuto D, Giovanetti M, Angeletti S, Ciccozzi M, Pascarella S (2020) Sars-CoV-2 envelope and membrane proteins: structural differences linked to virus characteristics? Biomed Res Int 2020:e4389089. https:\/\/doi.org\/10.1155\/2020\/4389089","journal-title":"Biomed Res Int"},{"key":"386_CR8","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.pdpdt.2017.01.187","volume":"18","author":"KC Blanco","year":"2017","unstructured":"Blanco KC, Inada NM, Carbinatto FM, Giusti AL, Bagnato VS (2017) Treatment of recurrent pharyngotonsillitis by photodynamic therapy. Photodiagn Photodyn Ther 18:138\u2013139. https:\/\/doi.org\/10.1016\/j.pdpdt.2017.01.187","journal-title":"Photodiagn Photodyn Ther"},{"key":"386_CR9","doi-asserted-by":"publisher","unstructured":"Bonotti M, Zech ST (2021) The human, economic, social, and political costs of COVID-19. Recovering Civility During COVID-19. https:\/\/doi.org\/10.1007\/978-981-33-6706-7_1.","DOI":"10.1007\/978-981-33-6706-7_1"},{"key":"386_CR10","doi-asserted-by":"publisher","DOI":"10.1101\/2020.09.12.293498","author":"B Boras","year":"2020","unstructured":"Boras B, Jones RM, Anson BJ, Arenson D, Aschenbrenner L, Bakowski MA, Beutler N, Binder J, Chen E, Eng H, Hammond J, Hoffman R, Kadar EP, Kania R, Kimoto E, Kirkpatrick MG, Lanyon L, Lendy EK, Lillis JR, Luthra SA, Ma C, Noell S, Obach RS, Brien MNO, O\u2019Connor R, Ogilvie K, Owen D, Pettersson M, Reese MR, Rogers TF, Rossulek MI, Sathish JG, Steppan C, Ticehurst M, Updyke LW, Zhu Y, Wang J, Chatterjee AK, Mesecar AD, Anderson AS, Allerton C (2020) Discovery of a novel inhibitor of coronavirus 3CL protease as a clinical candidate for the potential treatment of COVID-19. BioRxiv. https:\/\/doi.org\/10.1101\/2020.09.12.293498","journal-title":"BioRxiv"},{"issue":"1","key":"386_CR11","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.chempr.2019.10.013","volume":"6","author":"E Boros","year":"2020","unstructured":"Boros E, Dyson PJ, Gasser G (2020) Classification of metal-based drugs according to their mechanisms of action. Chem 6(1):41\u201360. https:\/\/doi.org\/10.1016\/j.chempr.2019.10.013","journal-title":"Chem"},{"issue":"4","key":"386_CR12","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1111\/j.1747-0285.2008.00647.x","volume":"71","author":"ET Brower","year":"2008","unstructured":"Brower ET, Bacha UM, Kawasaki Y, Freire E (2008) Inhibition of HIV-2 protease by HIV-1 protease inhibitors in clinical use. Chem Biol Drug Des 71(4):298\u2013305. https:\/\/doi.org\/10.1111\/j.1747-0285.2008.00647.x","journal-title":"Chem Biol Drug Des"},{"key":"386_CR13","unstructured":"COVID-19: EMA starts rolling review of molnupiravir - European Medicines Agency [Internet]. European Medicines Agency. 2021. https:\/\/www.ema.europa.eu\/en\/news\/covid-19-ema-starts-rolling-review-molnupiravir. Accessed 24 Nov 2021"},{"key":"386_CR14","unstructured":"COVID-19 Vaccine Tracker. https:\/\/vac-lshtm.shinyapps.io\/ncov_vaccine_landscape\/. Accessed 24 June 2021"},{"key":"386_CR15","unstructured":"COVID-19 First In Human Study to Evaluate Safety, Tolerability, and Pharmacokinetics of EIDD-2801 in Healthy Volunteers - Full-Text View - ClinicalTrials.gov [Internet]. Clinicaltrials.gov. 2021. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04392219?term=Molnupiravir&draw=2&rank=5. Accessed 24 Nov 2021"},{"key":"386_CR16","unstructured":"Carter DE Oxidation-reduction reactions of metal ions. 3"},{"issue":"6","key":"386_CR17","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.3390\/ph3061711","volume":"3","author":"EL Chang","year":"2010","unstructured":"Chang EL, Simmers C, Knight DA (2010) Cobalt complexes as antiviral and antibacterial agents. Pharmaceuticals 3(6):1711\u20131728. https:\/\/doi.org\/10.3390\/ph3061711","journal-title":"Pharmaceuticals"},{"issue":"1","key":"386_CR18","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1186\/s12866-020-01890-9","volume":"20","author":"K-K Chen","year":"2020","unstructured":"Chen K-K, Minakuchi M, Wuputra K, Ku C-C, Pan J-B, Kuo K-K, Lin Y-C, Saito S, Lin C-S, Yokoyama KK (2020) Redox control in the pathophysiology of influenza virus infection. BMC Microbiol 20(1):214. https:\/\/doi.org\/10.1186\/s12866-020-01890-9","journal-title":"BMC Microbiol"},{"issue":"1","key":"386_CR19","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1080\/17460441.2020.1819236","volume":"16","author":"D Cirri","year":"2021","unstructured":"Cirri D, Pratesi A, Marzo T, Messori L (2021) Metallo therapeutics for COVID-19. Exploiting metal-based compounds for the discovery of new antiviral drugs. Exp Opin Drug Discovery 16(1):39\u201346. https:\/\/doi.org\/10.1080\/17460441.2020.1819236","journal-title":"Exp Opin Drug Discovery"},{"issue":"3","key":"386_CR20","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1155\/MBD.1997.173","volume":"4","author":"E De Clercq","year":"1997","unstructured":"De Clercq E (1997) Antiviral metal complexes. Met-Based Drugs 4(3):173\u2013192. https:\/\/doi.org\/10.1155\/MBD.1997.173","journal-title":"Met-Based Drugs"},{"key":"386_CR92","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2020.110493","volume":"129","author":"WG dos Santos","year":"2020","unstructured":"dos Santos WG (2020) Natural history of COVID-19 and current knowledge on treatment therapeutic options. Biomed Pharmacother 129:110493. https:\/\/doi.org\/10.1016\/j.biopha.2020.110493","journal-title":"Biomed Pharmacother"},{"key":"386_CR21","unstructured":"Commissioner O. of the. FDA Approves First Treatment for COVID-19. https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-approves-first-treatment-covid-19. Accessed 24 June 2021"},{"key":"386_CR22","unstructured":"Coronavirus (COVID-19) Vaccinations - Statistics and Research. https:\/\/ourworldindata.org\/covid-vaccinations. Accessed 24 June 2021"},{"issue":"3\u20134","key":"386_CR23","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.pdpdt.2009.10.008","volume":"6","author":"T Dai","year":"2009","unstructured":"Dai T, Huang Y-Y, Hamblin MR (2009) Photodynamic therapy for localized infections \u2013 State of the Art. Photodiagnosis Photodyn Ther 6(3\u20134):170\u2013188. https:\/\/doi.org\/10.1016\/j.pdpdt.2009.10.008","journal-title":"Photodiagnosis Photodyn Ther"},{"key":"386_CR24","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2020.608435","volume":"10","author":"S Damiano","year":"2020","unstructured":"Damiano S, Sozio C, La Rosa G, Santillo M (2020) NOX-dependent signaling dysregulation in severe COVID-19: clues to effective treatments. Front Cell Infect Microbiol 10:608435. https:\/\/doi.org\/10.3389\/fcimb.2020.608435","journal-title":"Front Cell Infect Microbiol"},{"key":"386_CR25","doi-asserted-by":"publisher","first-page":"101804","DOI":"10.1016\/j.pdpdt.2020.101804","volume":"31","author":"LD Dias","year":"2020","unstructured":"Dias LD, Blanco KC, Bagnato VS (2020) COVID-19: beyond the virus. The use of photodynamic therapy for the treatment of infections in the respiratory tract. Photodiagnosis Photodyn Ther 31:101804. https:\/\/doi.org\/10.1016\/j.pdpdt.2020.101804","journal-title":"Photodiagnosis Photodyn Ther"},{"issue":"5","key":"386_CR26","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1016\/j.ijantimicag.2019.08.001","volume":"54","author":"RS Diaz","year":"2019","unstructured":"Diaz RS, Shytaj IL, Giron LB, Obermaier B, Della Libera E, Galinskas J, Dias D, Hunter J, Janini M, Gossen G, Ferreira PA, Sucupira MC, Maricato J, Fackler O, Lusic M, Savarino A (2019) Potential impact of the antirheumatic agent auranofin on proviral HIV-1 DNA in individuals under intensified antiretroviral therapy: results from a randomised clinical trial. Int J Antimicrobial Agents 54(5):592\u2013600. https:\/\/doi.org\/10.1016\/j.ijantimicag.2019.08.001","journal-title":"Int J Antimicrobial Agents"},{"key":"386_CR27","unstructured":"Efficacy and Safety of Molnupiravir (MK-4482) in Non-Hospitalized Adult Participants With COVID-19 (MK-4482-002) - Full Text View - ClinicalTrials.gov [Internet]. Clinicaltrials.gov. 2021. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04575597?term=Molnupiravir&draw=2&rank=2. Accessed 24 Nov 2021"},{"key":"386_CR28","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/1471-2415-6-22","volume":"6","author":"SP Epstein","year":"2006","unstructured":"Epstein SP, Pashinsky YY, Gershon D, Winicov I, Srivilasa C, Kristic KJ, Asbell PA (2006) Efficacy of topical cobalt chelate CTC-96 against adenovirus in a cell culture model and adenovirus keratoconjunctivitis in a rabbit model. BMC Ophthalmol 6:22. https:\/\/doi.org\/10.1186\/1471-2415-6-22","journal-title":"BMC Ophthalmol"},{"key":"386_CR29","unstructured":"FDA to Hold Advisory Committee Meeting to Discuss Merck and Ridgeback's EUA Application for COVID-19 Oral Treatment [Internet]. U.S. Food and Drug Administration. 2021. https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-hold-advisory-committee-meeting-discuss-merck-and-ridgebacks-eua-application-covid-19-oral. Accessed 24 Nov 2021"},{"key":"386_CR30","unstructured":"Favipiravir (T-705), A Broad-Spectrum Inhibitor of Viral RNA Polymerase. https:\/\/www.jstage.jst.go.jp\/article\/pjab\/93\/7\/93_PJA9307B-02\/_article\/-char\/ja\/. Accessed 26 June 2021"},{"key":"386_CR31","unstructured":"First oral antiviral for COVID-19, Lagevrio (molnupiravir), approved by MHRA [Internet]. GOV.UK. 2021. Available from: https:\/\/www.gov.uk\/government\/news\/first-oral-antiviral-for-covid-19-lagevrio-molnupiravir-approved-by-mhra. Accessed 24 Nov 2021"},{"issue":"2","key":"386_CR32","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1021\/acs.chemrev.8b00685","volume":"119","author":"KJ Franz","year":"2019","unstructured":"Franz KJ, Metzler-Nolte N (2019) Introduction: metals in medicine. Chem Rev 119(2):727\u2013729. https:\/\/doi.org\/10.1021\/acs.chemrev.8b00685","journal-title":"Chem Rev"},{"issue":"6","key":"386_CR33","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1358\/dnp.2003.16.6.829307","volume":"16","author":"DN Frick","year":"2003","unstructured":"Frick DN (2003) Helicases as antiviral drug targets. Drug News Perspect 16(6):355\u2013362","journal-title":"Drug News Perspect"},{"issue":"3","key":"386_CR34","doi-asserted-by":"publisher","first-page":"257","DOI":"10.2174\/0929867033368484","volume":"10","author":"MA Fuertes","year":"2003","unstructured":"Fuertes MA, Castilla J, Alonso C, P\u00e9rez JM (2003) Cisplatin biochemical mechanism of action: from cytotoxicity to induction of cell death through interconnections between apoptotic and necrotic pathways. Curr Med Chem 10(3):257\u2013266. https:\/\/doi.org\/10.2174\/0929867033368484","journal-title":"Curr Med Chem"},{"key":"386_CR35","doi-asserted-by":"publisher","first-page":"296","DOI":"10.3389\/fmicb.2014.00296","volume":"5","author":"TS Fung","year":"2014","unstructured":"Fung TS, Liu DX (2014) Coronavirus infection, ER stress, apoptosis, and innate immunity. Front Microbiol 5:296. https:\/\/doi.org\/10.3389\/fmicb.2014.00296","journal-title":"Front Microbiol"},{"issue":"6492","key":"386_CR36","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1126\/science.abb7498","volume":"368","author":"Y Gao","year":"2020","unstructured":"Gao Y, Yan L, Huang Y, Liu F, Zhao Y, Cao L, Wang T, Sun Q, Ming Z, Zhang L, Ge J, Zheng L, Zhang Y, Wang H, Zhu Y, Zhu C, Hu T, Hua T, Zhang B, Yang X, Li J, Yang H, Liu Z, Xu W, Guddat LW, Wang Q, Lou Z, Rao Z (2020) Structure of the RNA-dependent RNA polymerase from COVID-19 virus. Science 368(6492):779\u2013782. https:\/\/doi.org\/10.1126\/science.abb7498","journal-title":"Science"},{"issue":"21","key":"386_CR37","doi-asserted-by":"publisher","first-page":"12359","DOI":"10.1021\/acs.jmedchem.0c00606","volume":"63","author":"C Gil","year":"2020","unstructured":"Gil C, Ginex T, Maestro I, Nozal V, Barrado-Gil L, Cuesta-Geijo M et al (2020) COVID-19: drug targets and potential treatments. J Med Chem 63(21):12359\u201312386","journal-title":"J Med Chem"},{"issue":"66","key":"386_CR38","doi-asserted-by":"publisher","first-page":"15140","DOI":"10.1002\/chem.202004112","volume":"26","author":"M Gil-Moles","year":"2020","unstructured":"Gil-Moles M, Basu U, B\u00fcssing R, Hoffmeister H, T\u00fcrck S, Varchmin A, Ott I (2020) Gold metallodrugs to target coronavirus proteins: inhibitory effects on the spike-ACE2 interaction and PLpro protease activity by auranofin and gold organometallics. Chem 26(66):15140\u201315144. https:\/\/doi.org\/10.1002\/chem.202004112","journal-title":"Chem"},{"key":"386_CR39","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.virol.2014.10.037","volume":"475","author":"RC Gullberg","year":"2015","unstructured":"Gullberg RC, Jordan Steel J, Moon SL, Soltani E, Geiss BJ (2015) Oxidative stress influences positive strand RNA virus genome synthesis and capping. Virology 475:219\u2013229. https:\/\/doi.org\/10.1016\/j.virol.2014.10.037","journal-title":"Virology"},{"key":"386_CR40","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.mib.2016.06.008","volume":"33","author":"MR Hamblin","year":"2016","unstructured":"Hamblin MR (2016) Antimicrobial photodynamic inactivation: a bright new technique to kill resistant microbes. Curr Opin Microbiol 33:67\u201373. https:\/\/doi.org\/10.1016\/j.mib.2016.06.008","journal-title":"Curr Opin Microbiol"},{"issue":"14","key":"386_CR41","doi-asserted-by":"publisher","first-page":"4453","DOI":"10.1073\/pnas.1504022112","volume":"112","author":"MB Harbut","year":"2015","unstructured":"Harbut MB, Vilch\u00e8ze C, Luo X, Hensler ME, Guo H, Yang B, Chatterjee AK, Nizet V, Jacobs WR, Schultz PG, Wang F (2015) Auranofin exerts broad-spectrum bactericidal activities by targeting thiol-redox homeostasis. Proc Natl Acad Sci USA 112(14):4453\u20134458. https:\/\/doi.org\/10.1073\/pnas.1504022112","journal-title":"Proc Natl Acad Sci USA"},{"issue":"5","key":"386_CR42","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1007\/s10147-003-0354-4","volume":"8","author":"H Ichimura","year":"2003","unstructured":"Ichimura H, Yamaguchi S, Kojima A, Tanaka T, Niiya K, Takemori M, Hasegawa K, Nishimura R (2003) Eradication and reinfection of human papillomavirus after photodynamic therapy for cervical intraepithelial Neoplasia. Int J Clin Oncol 8(5):322\u2013325. https:\/\/doi.org\/10.1007\/s10147-003-0354-4","journal-title":"Int J Clin Oncol"},{"issue":"1","key":"386_CR43","doi-asserted-by":"publisher","first-page":"vew014","DOI":"10.1093\/ve\/vew014","volume":"2","author":"K Irwin","year":"2016","unstructured":"Irwin K, Renzetti N, Kowalik T, Jensen J (2016) Antiviral drug resistance as an adaptive process. Virus Evol 2(1):vew014","journal-title":"Virus Evol"},{"key":"386_CR44","doi-asserted-by":"crossref","unstructured":"Ivan Lozada M, Daniela Torres L, Maria Bola\u00f1o R, Luis Moscote S (2020) High mutation rate in SARS-CoV-2: will it hit us the same way forever? J Infect Dis Epidemiol 6(6)","DOI":"10.23937\/2474-3658\/1510176"},{"key":"386_CR45","doi-asserted-by":"publisher","first-page":"204020661876448","DOI":"10.1177\/2040206618764483","volume":"26","author":"PC Jordan","year":"2018","unstructured":"Jordan PC, Stevens SK, Deval J (2018) Nucleosides for the treatment of respiratory RNA virus infections. Antivir Chem Chemother 26:2040206618764483. https:\/\/doi.org\/10.1177\/2040206618764483","journal-title":"Antivir Chem Chemother"},{"key":"386_CR46","doi-asserted-by":"publisher","DOI":"10.1155\/2008\/276109","volume":"2008","author":"LB Josefsen","year":"2008","unstructured":"Josefsen LB, Boyle RW (2008) Photodynamic therapy and the development of metal-based photosensitisers. Met-Based Drugs 2008:e276109. https:\/\/doi.org\/10.1155\/2008\/276109","journal-title":"Met-Based Drugs"},{"issue":"4","key":"386_CR47","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1089\/ars.2010.3663","volume":"15","author":"U Jungwirth","year":"2011","unstructured":"Jungwirth U, Kowal CR, Keppler BK, Hartinger CG, Berger W, Heffeter P (2011) Anticancer activity of metal complexes: involvement of redox processes. Antioxid Redox Signal 15(4):1085\u20131127. https:\/\/doi.org\/10.1089\/ars.2010.3663","journal-title":"Antioxid Redox Signal"},{"issue":"11","key":"386_CR48","doi-asserted-by":"publisher","first-page":"5616","DOI":"10.1016\/j.ejmech.2011.09.031","volume":"46","author":"A Karak\u00fc\u00e7\u00fck-\u0130yido\u011fan","year":"2011","unstructured":"Karak\u00fc\u00e7\u00fck-\u0130yido\u011fan A, Ta\u015fdemir D, Oru\u00e7-Emre EE, Balzarini J (2011) Novel platinum(ii) and palladium(ii) complexes of thiosemicarbazones derived from 5-substitutedthiophene-2-carboxaldehydes and their antiviral and cytotoxic activities. Eur J Med Chem 46(11):5616\u20135624. https:\/\/doi.org\/10.1016\/j.ejmech.2011.09.031","journal-title":"Eur J Med Chem"},{"key":"386_CR49","doi-asserted-by":"publisher","DOI":"10.1002\/cbic.202100186","author":"J Karges","year":"2021","unstructured":"Karges J, Cohen SM (2021) Metal complexes as antiviral agents for SARS-CoV-2. ChemBioChem. https:\/\/doi.org\/10.1002\/cbic.202100186","journal-title":"ChemBioChem"},{"issue":"4","key":"386_CR50","doi-asserted-by":"publisher","first-page":"e201800189","DOI":"10.1002\/jbio.201800189","volume":"12","author":"G Kassab","year":"2019","unstructured":"Kassab G, Gerald MC, Inada NM, Achilles AE, Guerra VG, Bagnato VS (2019) Nebulization as a tool for photosensitizer delivery to the respiratory tract. J Biophotonics 12(4):e201800189. https:\/\/doi.org\/10.1002\/jbio.201800189","journal-title":"J Biophotonics"},{"issue":"12","key":"386_CR51","doi-asserted-by":"publisher","first-page":"2948","DOI":"10.1111\/trf.13860","volume":"56","author":"SD Keil","year":"2016","unstructured":"Keil SD, Bowen R, Marschner S (2016) Inactivation of middle east respiratory syndrome coronavirus (MERS-CoV) in plasma products using a riboflavin-based and ultraviolet light-based photochemical treatment. Transfusion 56(12):2948\u20132952. https:\/\/doi.org\/10.1111\/trf.13860","journal-title":"Transfusion"},{"issue":"8","key":"386_CR52","doi-asserted-by":"publisher","first-page":"392","DOI":"10.3390\/v10080392","volume":"10","author":"OA Khomich","year":"2018","unstructured":"Khomich OA, Kochetkov SN, Bartosch B, Ivanov AV (2018) Redox biology of respiratory viral infections. Viruses 10(8):392. https:\/\/doi.org\/10.3390\/v10080392","journal-title":"Viruses"},{"issue":"4","key":"386_CR53","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1111\/j.1365-2567.2007.02679.x","volume":"122","author":"N-H Kim","year":"2007","unstructured":"Kim N-H, Lee M-Y, Park S-J, Choi J-S, Oh M-K, Kim I-S (2007) Auranofin blocks interleukin-6 signalling by inhibiting phosphorylation of JAK1 and STAT3. Immunology 122(4):607\u2013614. https:\/\/doi.org\/10.1111\/j.1365-2567.2007.02679.x","journal-title":"Immunology"},{"issue":"11","key":"386_CR54","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1038\/s41566-020-00703-9","volume":"14","author":"N Kipshidze","year":"2020","unstructured":"Kipshidze N, Yeo N, Kipshidze N (2020) Photodynamic therapy for COVID-19. Nat Photonics 14(11):651\u2013652. https:\/\/doi.org\/10.1038\/s41566-020-00703-9","journal-title":"Nat Photonics"},{"issue":"1","key":"386_CR55","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/s12985-021-01526-y","volume":"18","author":"ZA Krumm","year":"2021","unstructured":"Krumm ZA, Lloyd GM, Francis CP, Nasif LH, Mitchell DA, Golde TE, Giasson BI, Xia Y (2021) Precision therapeutic targets for COVID-19. Virol J 18(1):66. https:\/\/doi.org\/10.1186\/s12985-021-01526-y","journal-title":"Virol J"},{"issue":"3","key":"386_CR56","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1039\/D0MD00318B","volume":"12","author":"R Kumar","year":"2021","unstructured":"Kumar R, Mishra S, Shreya; Maurya, S. K, (2021) Recent advances in the discovery of potent RNA-dependent RNA-polymerase (RdRp) inhibitors targeting viruses. RSC Med Chem 12(3):306\u2013320. https:\/\/doi.org\/10.1039\/D0MD00318B","journal-title":"RSC Med Chem"},{"issue":"3","key":"386_CR57","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1021\/acsptsci.0c00216","volume":"4","author":"M Kuzikov","year":"2021","unstructured":"Kuzikov M, Costanzi E, Reinshagen J, Esposito F, Vangeel L, Wolf M, Ellinger B, Claussen C, Geisslinger G, Corona A, Iaconis D, Talarico C, Manelfi C, Cannalire R, Rossetti G, Gossen J, Albani S, Musiani F, Herzog K, Ye Y, Giabbai B, Demitri N, Jochmans D, Jonghe SD, Rymenants J, Summa V, Tramontano E, Beccari AR, Leyssen P, Storici P, Neyts J, Gribbon P, Zaliani A (2021) Identification of inhibitors of SARS-CoV-2 3CLpro enzymatic activity using a small molecule in vitro repurposing screen. ACS Pharmacol Transl Sci 4(3):1096\u20131110. https:\/\/doi.org\/10.1021\/acsptsci.0c00216","journal-title":"ACS Pharmacol Transl Sci"},{"issue":"1","key":"386_CR58","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/s0166-3542(96)01207-7","volume":"34","author":"F K\u00e4sermann","year":"1997","unstructured":"K\u00e4sermann F, Kempf C (1997) Photodynamic inactivation of enveloped viruses by buckminsterfullerene. Antiviral Res 34(1):65\u201370. https:\/\/doi.org\/10.1016\/s0166-3542(96)01207-7","journal-title":"Antiviral Res"},{"issue":"7807","key":"386_CR59","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1038\/s41586-020-2180-5","volume":"581","author":"J Lan","year":"2020","unstructured":"Lan J, Ge J, Yu J, Shan S, Zhou H, Fan S, Zhang Q, Shi X, Wang Q, Zhang L, Wang X (2020) Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor. Nature 581(7807):215\u2013220. https:\/\/doi.org\/10.1038\/s41586-020-2180-5","journal-title":"Nature"},{"issue":"13","key":"386_CR60","doi-asserted-by":"publisher","DOI":"10.1002\/adhm.201900132","volume":"8","author":"M Lan","year":"2019","unstructured":"Lan M, Zhao S, Liu W, Lee C-S, Zhang W, Wang P (2019) Photosensitizers for photodynamic therapy. Adv Healthc Mater 8(13):e1900132. https:\/\/doi.org\/10.1002\/adhm.201900132","journal-title":"Adv Healthc Mater"},{"issue":"6965","key":"386_CR61","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1038\/nature02145","volume":"426","author":"W Li","year":"2003","unstructured":"Li W, Moore MJ, Vasilieva N, Sui J, Wong SK, Berne MA, Somasundaran M, Sullivan JL, Luzuriaga K, Greenough TC, Choe H, Farzan M (2003) Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature 426(6965):450\u2013454. https:\/\/doi.org\/10.1038\/nature02145","journal-title":"Nature"},{"issue":"3","key":"386_CR62","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1189\/jlb.72.3.429","volume":"72","author":"S Mahalingam","year":"2002","unstructured":"Mahalingam S, Meanger J, Foster PS, Lidbury BA (2002) The viral manipulation of the host cellular and immune environments to enhance propagation and survival: a focus on RNA viruses. J Leukoc Biol 72(3):429\u2013439","journal-title":"J Leukoc Biol"},{"issue":"6","key":"386_CR63","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1021\/acsmedchemlett.0c00190","volume":"11","author":"T Marzo","year":"2020","unstructured":"Marzo T, Messori L (2020) A role for metal-based drugs in fighting COVID-19 infection? The case of auranofin. ACS Med Chem Lett 11(6):1067\u20131068. https:\/\/doi.org\/10.1021\/acsmedchemlett.0c00190","journal-title":"ACS Med Chem Lett"},{"key":"386_CR64","doi-asserted-by":"publisher","first-page":"336","DOI":"10.3389\/fmicb.2018.00336","volume":"9","author":"HC May","year":"2018","unstructured":"May HC, Yu J-J, Guentzel MN, Chambers JP, Cap AP, Arulanandam BP (2018) Repurposing auranofin, ebselen, and PX-12 as antimicrobial agents targeting the thioredoxin system. Front Microbiol 9:336. https:\/\/doi.org\/10.3389\/fmicb.2018.00336","journal-title":"Front Microbiol"},{"key":"386_CR65","doi-asserted-by":"publisher","unstructured":"McGuire L, Hogge J, Hintze A, Liddle N, Nelson N, Pollock J, Brown A, Facer S, Walker S, Lynch J, Harrison RG, Busath DD (2020) Copper Complexes as Influenza Antivirals: Reduced Zebrafish Toxicity. In: Marius Avramescu S, Akhtar K, Fierascu I, Bahadar Khan S, Ali FM, Asiri A (eds) Engineered Nanomaterials - Health and Safety, IntechOpen. https:\/\/doi.org\/10.5772\/intechopen.88786.","DOI":"10.5772\/intechopen.88786"},{"key":"386_CR66","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.ccr.2018.03.020","volume":"379","author":"LK McKenzie","year":"2019","unstructured":"McKenzie LK, Bryant HE, Weinstein JA (2019) Transition metal complexes as photosensitisers in one- and two-photon photodynamic therapy. Coord Chem Rev 379:2\u201329. https:\/\/doi.org\/10.1016\/j.ccr.2018.03.020","journal-title":"Coord Chem Rev"},{"issue":"10229","key":"386_CR67","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1016\/S0140-6736(20)30628-0","volume":"395","author":"P Mehta","year":"2020","unstructured":"Mehta P, McAuley DF, Brown M, Sanchez E, Tattersall RS, Manson JJ (2020) COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet 395(10229):1033\u20131034. https:\/\/doi.org\/10.1016\/S0140-6736(20)30628-0","journal-title":"Lancet"},{"issue":"3","key":"386_CR68","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1089\/ars.2013.5818","volume":"22","author":"Y Meng","year":"2015","unstructured":"Meng Y, Li T, Zhou G-S, Chen Y, Yu C-H, Pang M-X, Li W, Li Y, Zhang W-Y, Li X (2015) The angiotensin-converting enzyme 2\/angiotensin (1\u20137)\/Mas axis protects against lung fibroblast migration and lung fibrosis by inhibiting the NOX4-derived ROS-mediated RhoA\/Rho kinase pathway. Antioxid Redox Signal 22(3):241\u2013258. https:\/\/doi.org\/10.1089\/ars.2013.5818","journal-title":"Antioxid Redox Signal"},{"key":"386_CR69","doi-asserted-by":"publisher","DOI":"10.1016\/j.pdpdt.2020.101889","volume":"31","author":"K Moghissi","year":"2020","unstructured":"Moghissi K, Dixon K, Gibbins S (2020) Does PDT have potential in treating COVID 19 patients? Photodiagn Photodyn Ther 31:101889. https:\/\/doi.org\/10.1016\/j.pdpdt.2020.101889","journal-title":"Photodiagn Photodyn Ther"},{"key":"386_CR70","doi-asserted-by":"publisher","first-page":"599","DOI":"10.2147\/DDDT.S119488","volume":"11","author":"U Nagi","year":"2017","unstructured":"Nagi U, Mhlongo N, Soliman ME (2017) Metal complexes in cancer therapy\u2014an update from drug design perspective. DDDT 11:599\u2013616. https:\/\/doi.org\/10.2147\/DDDT.S119488","journal-title":"DDDT"},{"key":"386_CR71","unstructured":"Nareetsile F, Ndlovu S, Matshwele JTP, Ngaski M (2020) Transition metal complexes with HIV\/AIDS inhibitory properties 21"},{"issue":"23","key":"386_CR72","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1016\/j.drudis.2010.10.005","volume":"15","author":"M Navarro","year":"2010","unstructured":"Navarro M, Gabbiani C, Messori L, Gambino D (2010) Metal-based drugs for malaria, trypanosomiasis, and leishmaniasis: recent achievements and perspectives. Drug Discovery Today 15(23):1070\u20131078. https:\/\/doi.org\/10.1016\/j.drudis.2010.10.005","journal-title":"Drug Discovery Today"},{"issue":"3","key":"386_CR73","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1177\/0897190021997001","volume":"34","author":"M Naveed","year":"2021","unstructured":"Naveed M, Uddin S, Khan MK, Khan Z (2021) Remdesivir for the treatment of COVID-19: a need for combined in vivo and in vitro studies to evaluate the efficacy. J Pharm Pract 34(3):343\u2013346. https:\/\/doi.org\/10.1177\/0897190021997001","journal-title":"J Pharm Pract"},{"issue":"23","key":"386_CR74","doi-asserted-by":"publisher","first-page":"16004","DOI":"10.1074\/jbc.M900146200","volume":"284","author":"L Nencioni","year":"2009","unstructured":"Nencioni L, De Chiara G, Sgarbanti R, Amatore D, Aquilano K, Marcocci ME, Serafino A, Torcia M, Cozzolino F, Ciriolo MR, Garaci E, Palamara AT (2009) Bcl-2 expression and P38MAPK activity in cells infected with influenza a virus: impact on virally induced apoptosis and viral replication. J Biol Chem 284(23):16004\u201316015. https:\/\/doi.org\/10.1074\/jbc.M900146200","journal-title":"J Biol Chem"},{"issue":"35","key":"386_CR75","doi-asserted-by":"publisher","first-page":"3898","DOI":"10.2174\/138161211798357728","volume":"17","author":"L Nencioni","year":"2011","unstructured":"Nencioni L, Sgarbanti R, Amatore D, Checconi P, Celestino I, Limongi D, Anticoli S, Palamara AT, Garaci E (2011) Intracellular redox signaling as therapeutic target for novel antiviral strategy. Curr Pharm Des 17(35):3898\u20133904. https:\/\/doi.org\/10.2174\/138161211798357728","journal-title":"Curr Pharm Des"},{"key":"386_CR76","first-page":"21","volume":"36","author":"S Norn","year":"2008","unstructured":"Norn S, Permin H, Kruse E, Kruse PR (2008) Mercury-a significant agent in the history of medicine and alchemy. Dan Medicinhist Arbog 36:21\u201340","journal-title":"Dan Medicinhist Arbog"},{"issue":"1","key":"386_CR77","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1186\/s12967-020-02344-6","volume":"18","author":"M Pachetti","year":"2020","unstructured":"Pachetti M, Marini B, Benedetti F, Giudici F, Mauro E, Storici P, Masciovecchio C, Angeletti S, Ciccozzi M, Gallo RC, Zella D, Ippodrino R (2020) Emerging SARS-CoV-2 mutation hot spots include a novel RNA-dependent-RNA polymerase variant. J Translational Med 18(1):179. https:\/\/doi.org\/10.1186\/s12967-020-02344-6","journal-title":"J Translational Med"},{"issue":"45","key":"386_CR78","doi-asserted-by":"publisher","first-page":"16004","DOI":"10.1039\/D0DT02478C","volume":"49","author":"REF de Paiva","year":"2020","unstructured":"de Paiva REF, Mar\u00e7al Neto A, Santos IA, Jardim ACG, Corbi PP, Bergamini FRG (2020) What is holding back the development of antiviral metallodrugs? A literature overview and implications for SARS-CoV-2 therapeutics and future viral outbreaks. Dalton Trans 49(45):16004\u201316033. https:\/\/doi.org\/10.1039\/D0DT02478C","journal-title":"Dalton Trans"},{"issue":"24","key":"386_CR79","doi-asserted-by":"publisher","first-page":"8765","DOI":"10.1021\/jm1007616","volume":"53","author":"G Pelosi","year":"2010","unstructured":"Pelosi G, Bisceglie F, Bignami F, Ronzi P, Schiavone P, Re MC, Casoli C, Pilotti E (2010) Antiretroviral activity of thiosemicarbazone metal complexes. J Med Chem 53(24):8765\u20138769. https:\/\/doi.org\/10.1021\/jm1007616","journal-title":"J Med Chem"},{"issue":"777","key":"386_CR80","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1098\/rspb.1933.0010","volume":"112","author":"JR Perdrau","year":"1933","unstructured":"Perdrau JR, Todd C (1933) The photodynamic action of methylene blue on bacteriophage. Proceedings of the Royal Society of London Series B Containing Papers of a Biological Character 112(777):277\u2013287. https:\/\/doi.org\/10.1098\/rspb.1933.0010","journal-title":"Proceedings of the Royal Society of London Series B Containing Papers of a Biological Character"},{"key":"386_CR81","unstructured":"Photodynamic therapy in cancer treatment - an updated review https:\/\/jcmtjournal.com\/article\/view\/3026. Accessed 25 July 2021"},{"key":"386_CR82","doi-asserted-by":"publisher","unstructured":"Platinum and other metal coordination compounds in cancer chemotherapy: proceedings of the fifth international symposium on platinum and other metal coordination compounds in cancer chemotherapy Abano, Padua, Italy \u2014 June 29\u2013July 2, 1987, In: M. Nicolini (ed), Developments in Oncology; Springer US, 1988. https:\/\/doi.org\/10.1007\/978-1-4613-1717-3.","DOI":"10.1007\/978-1-4613-1717-3"},{"issue":"1","key":"386_CR83","doi-asserted-by":"publisher","first-page":"56","DOI":"10.4103\/ijp.IJP_115_20","volume":"52","author":"M Prajapat","year":"2020","unstructured":"Prajapat M, Sarma P, Shekhar N, Avti P, Sinha S, Kaur H, Kumar S, Bhattacharyya A, Kumar H, Bansal S, Medhi B (2020) Drug targets for coronavirus: a systematic review. Indian J Pharmacol 52(1):56\u201365. https:\/\/doi.org\/10.4103\/ijp.IJP_115_20","journal-title":"Indian J Pharmacol"},{"issue":"2","key":"386_CR84","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/BF03215464","volume":"29","author":"SP Pricker","year":"1996","unstructured":"Pricker SP (1996) Medical uses of gold compounds: past, present, and future. Gold Bull 29(2):53\u201360. https:\/\/doi.org\/10.1007\/BF03215464","journal-title":"Gold Bull"},{"issue":"3","key":"386_CR85","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2020.107940","volume":"32","author":"AJ Pruijssers","year":"2020","unstructured":"Pruijssers AJ, George AS, Sch\u00e4fer A, Leist SR, Gralinksi LE, Dinnon KH, Yount BL, Agostini ML, Stevens LJ, Chappell JD, Lu X, Hughes TM, Gully K, Martinez DR, Brown AJ, Graham RL, Perry JK, Du Pont V, Pitts J, Ma B, Babusis D, Murakami E, Feng JY, Bilello JP, Porter DP, Cihlar T, Baric RS, Denison MR, Sheahan TP (2020) Remdesivir inhibits SARS-CoV-2 in human lung cells and chimeric SARS-CoV expressing the SARS-CoV-2 RNA polymerase in mice. Cell Rep 32(3):107940. https:\/\/doi.org\/10.1016\/j.celrep.2020.107940","journal-title":"Cell Rep"},{"issue":"7","key":"386_CR86","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1038\/s41570-018-0018-6","volume":"2","author":"L Riccardi","year":"2018","unstructured":"Riccardi L, Genna V, De Vivo M (2018) Metal\u2013ligand interactions in drug design. Nat Rev Chem 2(7):100\u2013112. https:\/\/doi.org\/10.1038\/s41570-018-0018-6","journal-title":"Nat Rev Chem"},{"issue":"1","key":"386_CR87","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s40268-015-0083-y","volume":"15","author":"C Roder","year":"2015","unstructured":"Roder C, Thomson MJ (2015) Auranofin: repurposing an old drug for a golden new age. Drugs R D 15(1):13\u201320. https:\/\/doi.org\/10.1007\/s40268-015-0083-y","journal-title":"Drugs R D"},{"issue":"3","key":"386_CR88","doi-asserted-by":"publisher","first-page":"148","DOI":"10.3390\/pathogens8030148","volume":"8","author":"HA Rothan","year":"2019","unstructured":"Rothan HA, Kumar M (2019) Role of endoplasmic reticulum-associated proteins in flavivirus replication and assembly complexes. Pathogens 8(3):148. https:\/\/doi.org\/10.3390\/pathogens8030148","journal-title":"Pathogens"},{"key":"386_CR89","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.virol.2020.05.002","volume":"547","author":"HA Rothan","year":"2020","unstructured":"Rothan HA, Stone S, Natekar J, Kumari P, Arora K, Kumar M (2020) The FDA-approved gold drug auranofin inhibits novel coronavirus (SARS-COV-2) replication and attenuates inflammation in human cells. Virology 547:7\u201311. https:\/\/doi.org\/10.1016\/j.virol.2020.05.002","journal-title":"Virology"},{"issue":"6","key":"386_CR90","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1111\/j.1537-2995.2004.03355.x","volume":"44","author":"PH Ruane","year":"2004","unstructured":"Ruane PH, Edrich R, Gampp D, Keil SD, Leonard RL, Goodrich RP (2004) Photochemical inactivation of selected viruses and bacteria in platelet concentrates using riboflavin and light. Transfusion 44(6):877\u2013885. https:\/\/doi.org\/10.1111\/j.1537-2995.2004.03355.x","journal-title":"Transfusion"},{"key":"386_CR91","doi-asserted-by":"publisher","unstructured":"SARS-coronavirus replication is supported by a reticulovesicular network of modified endoplasmic reticulum. https:\/\/journals.plos.org\/plosbiology\/article?id=https:\/\/doi.org\/10.1371\/journal.pbio.0060226. Accessed 26 June 2021","DOI":"10.1371\/journal.pbio.0060226"},{"issue":"1","key":"386_CR93","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s12977-015-0178-0","volume":"12","author":"A Savarino","year":"2015","unstructured":"Savarino A, Shytaj IL (2015) Chloroquine and beyond: exploring antirheumatic drugs to reduce immune hyperactivation in HIV\/AIDS. Retrovirology 12(1):51. https:\/\/doi.org\/10.1186\/s12977-015-0178-0","journal-title":"Retrovirology"},{"issue":"9","key":"386_CR94","doi-asserted-by":"publisher","first-page":"4117","DOI":"10.1128\/JVI.75.9.4117-4128.2001","volume":"75","author":"JA Schwartz","year":"2001","unstructured":"Schwartz JA, Lium EK, Silverstein SJ (2001) Herpes simplex virus type 1 entry is inhibited by the cobalt chelate complex CTC-96. J Virol 75(9):4117\u20134128. https:\/\/doi.org\/10.1128\/JVI.75.9.4117-4128.2001","journal-title":"J Virol"},{"issue":"6","key":"386_CR95","doi-asserted-by":"publisher","first-page":"102329","DOI":"10.1016\/j.dsx.2021.102329","volume":"15","author":"A Singh","year":"2021","unstructured":"Singh A, Singh A, Singh R, Misra A (2021) Molnupiravir in COVID-19: a systematic literature review. Diabetes Metab Syndr 15(6):102329","journal-title":"Diabetes Metab Syndr"},{"key":"386_CR96","doi-asserted-by":"publisher","unstructured":"Singh R, Sharma B (2018) Metal-based therapy in traditional and modern medicine systems. In: Rai M, Ingle AP, Medici S (eds), Biomedical applications of metals. Springer International Publishing: Cham, pp 195\u2013211. https:\/\/doi.org\/10.1007\/978-3-319-74814-6_9.","DOI":"10.1007\/978-3-319-74814-6_9"},{"key":"386_CR97","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/2045-3701-4-3","volume":"4","author":"K-L Siu","year":"2014","unstructured":"Siu K-L, Chan C-P, Kok K-H, Woo PC-Y, Jin D-Y (2014) Comparative analysis of the activation of unfolded protein response by spike proteins of severe acute respiratory syndrome coronavirus and human coronavirus HKU1. Cell Biosci 4:3. https:\/\/doi.org\/10.1186\/2045-3701-4-3","journal-title":"Cell Biosci"},{"issue":"1","key":"386_CR98","first-page":"1","volume":"14","author":"RK Sodhi","year":"2019","unstructured":"Sodhi RK, Paul S (2019) Metal complexes in medicine: an overview and update from drug design perspective. CTOIJ 14(1):1\u20138","journal-title":"CTOIJ"},{"key":"386_CR99","doi-asserted-by":"publisher","DOI":"10.1016\/j.pdpdt.2020.102112","volume":"33","author":"VA Svyatchenko","year":"2021","unstructured":"Svyatchenko VA, Nikonov SD, Mayorov AP, Gelfond ML, Loktev VB (2021) Antiviral photodynamic therapy: inactivation and inhibition of SARS-CoV-2 in vitro using methylene blue and radachlorin. Photodiagnosis Photodyn Ther 33:102112. https:\/\/doi.org\/10.1016\/j.pdpdt.2020.102112","journal-title":"Photodiagnosis Photodyn Ther"},{"issue":"4","key":"386_CR100","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1089\/pho.2006.24.528","volume":"24","author":"JP Tardivo","year":"2006","unstructured":"Tardivo JP, Giglio AD, Paschoal LH, Baptista MS (2006) New Photodynamic therapy protocol to treat AIDS-related kaposi\u2019s sarcoma. Photomed Laser Surg 24(4):528\u2013531. https:\/\/doi.org\/10.1089\/pho.2006.24.528","journal-title":"Photomed Laser Surg"},{"issue":"2","key":"386_CR101","first-page":"44","volume":"6","author":"R Tariq","year":"2021","unstructured":"Tariq R, Khalid UA, Kanwal S, Adnan F, Qasim M (2021) Photodynamic therapy: a rational approach toward COVID-19 management. J Expl Res Pharmacol 6(2):44\u201352","journal-title":"J Expl Res Pharmacol"},{"key":"386_CR102","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-319-07758-1_19","author":"MW Taylor","year":"2014","unstructured":"Taylor MW (2014) Vaccines against viral infections. Viruses and Man. https:\/\/doi.org\/10.1007\/978-3-319-07758-1_19","journal-title":"Viruses and Man"},{"issue":"2","key":"386_CR103","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1001271","volume":"7","author":"R Vlahos","year":"2011","unstructured":"Vlahos R, Sambas J, Bozinovski S, Broughton BRS, Drummond GR, Selemidis S (2011) Inhibition of NOX2 oxidase activity ameliorates influenza A virus-induced lung inflammation. PLoS Pathog 7(2):e1001271. https:\/\/doi.org\/10.1371\/journal.ppat.1001271","journal-title":"PLoS Pathog"},{"issue":"6A","key":"386_CR104","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/0002-9343(83)90481-3","volume":"75","author":"DT Walz","year":"1983","unstructured":"Walz DT, DiMartino MJ, Griswold DE, Intoccia AP, Flanagan TL (1983) Biologic actions and pharmacokinetic studies of auranofin. Am J Med 75(6A):90\u2013108. https:\/\/doi.org\/10.1016\/0002-9343(83)90481-3","journal-title":"Am J Med"},{"key":"386_CR105","doi-asserted-by":"publisher","first-page":"e61312","DOI":"10.7554\/eLife.61312","volume":"9","author":"Y Weisblum","year":"2020","unstructured":"Weisblum Y, Schmidt F, Zhang F, DaSilva J, Poston D, Lorenzi JC, Muecksch F, Rutkowska M, Hoffmann H-H, Michailidis E, Gaebler C, Agudelo M, Cho A, Wang Z, Gazumyan A, Cipolla M, Luchsinger L, Hillyer CD, Caskey M, Robbiani DF, Rice CM, Nussenzweig MC, Hatziioannou T, Bieniasz PD (2020) Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants. Elife 9:e61312. https:\/\/doi.org\/10.7554\/eLife.61312","journal-title":"Elife"},{"issue":"11","key":"386_CR106","doi-asserted-by":"publisher","first-page":"2565","DOI":"10.1039\/C9PP00211A","volume":"18","author":"A Wiehe","year":"2019","unstructured":"Wiehe A, O\u2019Brien JM, Senge MO (2019) Trends and targets in antiviral phototherapy. Photochem Photobiol Sci 18(11):2565\u20132612. https:\/\/doi.org\/10.1039\/C9PP00211A","journal-title":"Photochem Photobiol Sci"},{"key":"386_CR107","doi-asserted-by":"publisher","unstructured":"Wolf DC, Wolf CH, Rubin DT (2020) Temporal improvement of a COVID-19-Positive Crohn's disease patient treated with bismuth subsalicylate. Am J Gastroenterol https:\/\/doi.org\/10.14309\/ajg.0000000000000725","DOI":"10.14309\/ajg.0000000000000725"},{"issue":"6483","key":"386_CR108","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1126\/science.abb2507","volume":"367","author":"D Wrapp","year":"2020","unstructured":"Wrapp D, Wang N, Corbett KS, Goldsmith JA, Hsieh C-L, Abiona O, Graham BS, McLellan JS (2020) Cryo-EM structure of the 2019-NCoV spike in the prefusion conformation. Science 367(6483):1260\u20131263. https:\/\/doi.org\/10.1126\/science.abb2507","journal-title":"Science"},{"key":"386_CR109","doi-asserted-by":"publisher","unstructured":"Wu M-Y, Gu M, Leung J-K, Li X, Yuan Y, Shen C, Wang L, Zhao E, Chen S. A membrane-targeting photosensitizer with aggregation-induced emission characteristics for highly efficient photodynamic combat of human coronaviruses. Small https:\/\/doi.org\/10.1002\/smll.202101770.","DOI":"10.1002\/smll.202101770"},{"issue":"34","key":"386_CR110","doi-asserted-by":"publisher","first-page":"6464","DOI":"10.1002\/anie.200701021","volume":"46","author":"N Yang","year":"2007","unstructured":"Yang N, Tanner JA, Zheng B-J, Watt RM, He M-L, Lu L-Y, Jiang J-Q, Shum K-T, Lin Y-P, Wong K-L, Lin MCM, Kung H-F, Sun H, Huang J-D (2007) Bismuth complexes inhibit the SARS coronavirus. Angew Chem Int Ed 46(34):6464\u20136468. https:\/\/doi.org\/10.1002\/anie.200701021","journal-title":"Angew Chem Int Ed"},{"issue":"23","key":"386_CR111","doi-asserted-by":"publisher","first-page":"13190","DOI":"10.1073\/pnas.1835675100","volume":"100","author":"H Yang","year":"2003","unstructured":"Yang H, Yang M, Ding Y, Liu Y, Lou Z, Zhou Z, Sun L, Mo L, Ye S, Pang H, Gao GF, Anand K, Bartlam M, Hilgenfeld R, Rao Z (2003) The crystal structures of severe acute respiratory syndrome virus main protease and its complex with an inhibitor. Proc Natl Acad Sci USA 100(23):13190\u201313195. https:\/\/doi.org\/10.1073\/pnas.1835675100","journal-title":"Proc Natl Acad Sci USA"},{"issue":"11","key":"386_CR112","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1038\/s41564-020-00802-x","volume":"5","author":"S Yuan","year":"2020","unstructured":"Yuan S, Wang R, Chan JF-W, Zhang AJ, Cheng T, Chik KK-H, Ye Z-W, Wang S, Lee AC-Y, Jin L, Li H, Jin D-Y, Yuen K-Y, Sun H (2020) Metallodrug ranitidine bismuth citrate suppresses SARS-CoV-2 replication and relieves virus-associated pneumonia in Syrian hamsters. Nat Microbiol 5(11):1439\u20131448. https:\/\/doi.org\/10.1038\/s41564-020-00802-x","journal-title":"Nat Microbiol"}],"container-title":["BioMetals"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10534-022-00386-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10534-022-00386-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10534-022-00386-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,29]],"date-time":"2023-01-29T23:05:15Z","timestamp":1675033515000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10534-022-00386-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,24]]},"references-count":112,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["386"],"URL":"https:\/\/doi.org\/10.1007\/s10534-022-00386-5","relation":{},"ISSN":["0966-0844","1572-8773"],"issn-type":[{"value":"0966-0844","type":"print"},{"value":"1572-8773","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,24]]},"assertion":[{"value":"25 August 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 March 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no known competing financial interests or personal relationships that could have influenced the work reported in this paper.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}